169 related articles for article (PubMed ID: 16710316)
21. Alterations of lipid metabolism and gene expression in rat adipocytes during chronic olanzapine treatment.
Minet-Ringuet J; Even PC; Valet P; Carpéné C; Visentin V; Prévot D; Daviaud D; Quignard-Boulange A; Tomé D; de Beaurepaire R
Mol Psychiatry; 2007 Jun; 12(6):562-71. PubMed ID: 17211438
[TBL] [Abstract][Full Text] [Related]
22. Olanzapine effects on body composition, food preference, glucose metabolism and insulin sensitivity in the rat.
Smith GC; Vickers MH; Shepherd PR
Arch Physiol Biochem; 2011 Oct; 117(4):241-9. PubMed ID: 21671852
[TBL] [Abstract][Full Text] [Related]
23. Chronic treatment with olanzapine via a novel infusion pump induces adiposity in male rats.
Shobo M; Yamada H; Koakutsu A; Hamada N; Fujii M; Harada K; Ni K; Matsuoka N
Life Sci; 2011 Apr; 88(17-18):761-5. PubMed ID: 21356217
[TBL] [Abstract][Full Text] [Related]
24. Long term treatment with olanzapine mixed with the food in male rats induces body fat deposition with no increase in body weight and no thermogenic alteration.
Minet-Ringuet J; Even PC; Goubern M; Tomé D; de Beaurepaire R
Appetite; 2006 May; 46(3):254-62. PubMed ID: 16551485
[TBL] [Abstract][Full Text] [Related]
25. The distinct effects of subchronic antipsychotic drug treatment on macronutrient selection, body weight, adiposity, and metabolism in female rats.
Fell MJ; Anjum N; Dickinson K; Marshall KM; Peltola LM; Vickers S; Cheetham S; Neill JC
Psychopharmacology (Berl); 2007 Oct; 194(2):221-31. PubMed ID: 17581744
[TBL] [Abstract][Full Text] [Related]
26. Effects of olanzapine in male rats: enhanced adiposity in the absence of hyperphagia, weight gain or metabolic abnormalities.
Cooper GD; Pickavance LC; Wilding JP; Harrold JA; Halford JC; Goudie AJ
J Psychopharmacol; 2007 Jun; 21(4):405-13. PubMed ID: 17050655
[TBL] [Abstract][Full Text] [Related]
27. A parametric analysis of olanzapine-induced weight gain in female rats.
Cooper GD; Pickavance LC; Wilding JP; Halford JC; Goudie AJ
Psychopharmacology (Berl); 2005 Aug; 181(1):80-9. PubMed ID: 15778884
[TBL] [Abstract][Full Text] [Related]
28. Elevation of systolic blood pressure in an animal model of olanzapine induced weight gain.
Patil BM; Kulkarni NM; Unger BS
Eur J Pharmacol; 2006 Dec; 551(1-3):112-5. PubMed ID: 17046744
[TBL] [Abstract][Full Text] [Related]
29. A double-blind, placebo-controlled trial of sibutramine for olanzapine-associated weight gain.
Henderson DC; Copeland PM; Daley TB; Borba CP; Cather C; Nguyen DD; Louie PM; Evins AE; Freudenreich O; Hayden D; Goff DC
Am J Psychiatry; 2005 May; 162(5):954-62. PubMed ID: 15863798
[TBL] [Abstract][Full Text] [Related]
30. Effect of olanzapine on body composition and energy expenditure in adults with first-episode psychosis.
Graham KA; Perkins DO; Edwards LJ; Barrier RC; Lieberman JA; Harp JB
Am J Psychiatry; 2005 Jan; 162(1):118-23. PubMed ID: 15625209
[TBL] [Abstract][Full Text] [Related]
31. Olanzapine and weight gain.
Isaac MB; Isaac MT
Am J Psychiatry; 2005 Sep; 162(9):1764-5; author reply 1765. PubMed ID: 16135655
[No Abstract] [Full Text] [Related]
32. Melatonin reduces body weight gain and increases nocturnal activity in male Wistar rats.
Terrón MP; Delgado-Adámez J; Pariente JA; Barriga C; Paredes SD; Rodríguez AB
Physiol Behav; 2013 Jun; 118():8-13. PubMed ID: 23643827
[TBL] [Abstract][Full Text] [Related]
33. Daily melatonin administration at middle age suppresses male rat visceral fat, plasma leptin, and plasma insulin to youthful levels.
Rasmussen DD; Boldt BM; Wilkinson CW; Yellon SM; Matsumoto AM
Endocrinology; 1999 Feb; 140(2):1009-12. PubMed ID: 9927336
[TBL] [Abstract][Full Text] [Related]
34. Energy metabolism, leptin, and biochemical parameters are altered in rats subjected to the chronic administration of olanzapine.
Zugno AI; Barcelos M; Oliveira Ld; Canever L; Luca RD; Fraga DB; Matos MP; Rezin GT; Scaini G; Búrigo M; Streck EL; Quevedo J
Braz J Psychiatry; 2012 Jun; 34(2):168-75. PubMed ID: 22729413
[TBL] [Abstract][Full Text] [Related]
35. Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia.
Ascher-Svanum H; Stensland M; Zhao Z; Kinon BJ
BMC Psychiatry; 2005 Jan; 5():3. PubMed ID: 15649317
[TBL] [Abstract][Full Text] [Related]
36. The role of thermogenesis in antipsychotic drug-induced weight gain.
Stefanidis A; Verty AN; Allen AM; Owens NC; Cowley MA; Oldfield BJ
Obesity (Silver Spring); 2009 Jan; 17(1):16-24. PubMed ID: 19107124
[TBL] [Abstract][Full Text] [Related]
37. Two models for weight gain and hyperphagia as side effects of atypical antipsychotics in male rats: validation with olanzapine and ziprasidone.
Shobo M; Yamada H; Mihara T; Kondo Y; Irie M; Harada K; Ni K; Matsuoka N; Kayama Y
Behav Brain Res; 2011 Jan; 216(2):561-8. PubMed ID: 20816897
[TBL] [Abstract][Full Text] [Related]
38. A model for antipsychotic-induced obesity in the male rat.
Minet-Ringuet J; Even PC; Lacroix M; Tomé D; de Beaurepaire R
Psychopharmacology (Berl); 2006 Sep; 187(4):447-54. PubMed ID: 16783538
[TBL] [Abstract][Full Text] [Related]
39. Chronic treatment with olanzapine increases adiposity by changing fuel substrate and causes desensitization of the acute metabolic side effects.
Girault EM; Guigas B; Alkemade A; Foppen E; Ackermans MT; la Fleur SE; Fliers E; Kalsbeek A
Naunyn Schmiedebergs Arch Pharmacol; 2014 Feb; 387(2):185-95. PubMed ID: 24190543
[TBL] [Abstract][Full Text] [Related]
40. Estrogen replacement reverses olanzapine-induced weight gain and hepatic insulin resistance in ovariectomized diabetic rats.
Park S; Hong SM; Ahn IL; Kim DS; Kim SH
Neuropsychobiology; 2010; 61(3):148-61. PubMed ID: 20173353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
